Condition
Human Immunodeficiency Virus Transmission
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05619497Not ApplicableCompleted
The OPENS Trial: Offering Women PrEP (Aim 2)
NCT04621760Not ApplicableCompletedPrimary
The OPENS Trial: Offering Women PrEP (Aim 1)
NCT03617874Not ApplicableCompletedPrimary
PC4PrEP: Integrating PrEP Into Primary Care
NCT03984552UnknownPrimary
Validation of Rapid Tests for the Serological Diagnosis of HIV in 9 to 24 Months Old Children
Showing all 4 trials